OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
LIND59

Linde India Ltd

Commodity ChemicalsVerified

Linde India maintains a strong liquidity position with a current ratio of 0.95, indicating that its current assets are nearly equal to its current liabilities. The company's liquidity_fpt score is high, supported by a cash and equivalents balance of INR 1.26 billion, which provides a buffer against short-term obligations. However, the company reported a negative free cash flow of INR -7.64 billion, primarily due to a capital expenditure of INR -13.31 billion, which suggests significant reinvestment in its operations. In terms of profitability, Linde India's return on equity (ROE) of 11.91% and return on assets (ROA) of 8.84% are strong indicators of efficient capital utilization and asset management. These metrics are well above the industry median for Commodity Chemicals, suggesting that the company is outperforming its peers in generating returns for shareholders and effectively deploying its assets. The company's revenue is primarily concentrated in India, with no disclosed international operations in the latest financial snapshot. This geographic concentration may expose the company to local economic and regulatory risks, but it also allows for focused operational control and market penetration. Linde India's business is not segmented into multiple product lines in the provided data, but its primary activity is the production and distribution of industrial gases. Looking at the growth trajectory, Linde India's revenue for the latest period was INR 24.85 billion. While the outlook for the current fiscal year is not explicitly provided, the company's capital expenditure suggests a strategic focus on expansion and infrastructure development. The negative free cash flow indicates that the company is prioritizing growth over immediate shareholder returns, which could lead to higher revenue in the future. The risk assessment for Linde India indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.01 is exceptionally low, suggesting a conservative capital structure with minimal reliance on debt financing. This low leverage reduces financial risk and provides flexibility for future growth initiatives. The dilution risk is also low, with no signs of imminent share issuance or dilution pressure in the near term. Recent events and filings do not show any material changes in the company's operations or financial position. The analyst estimates suggest a mean price target of INR 6,742.67, with a median of INR 6,150.00, indicating a generally positive outlook from the market. The mean recommendation of 3.33 (on a scale of 1 to 5) suggests a cautious approach, with one "buy" and one "hold" recommendation from analysts.

30-day price · LIND+8.50 (+0.1%)
Low$6944.50High$8049.00Close$7248.50As of26 May, 00:00 UTC
Profile
CompanyLinde India Ltd
TickerLIND.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Linde India Ltd is a chemical manufacturing company that produces and distributes industrial gases and related products, primarily serving the industrial, healthcare, and energy sectors.

Classification. Linde India is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92 based on verified market data.

Linde India maintains a strong liquidity position with a current ratio of 0.95, indicating that its current assets are nearly equal to its current liabilities. The company's liquidity_fpt score is high, supported by a cash and equivalents balance of INR 1.26 billion, which provides a buffer against short-term obligations. However, the company reported a negative free cash flow of INR -7.64 billion, primarily due to a capital expenditure of INR -13.31 billion, which suggests significant reinvestment in its operations. In terms of profitability, Linde India's return on equity (ROE) of 11.91% and return on assets (ROA) of 8.84% are strong indicators of efficient capital utilization and asset management. These metrics are well above the industry median for Commodity Chemicals, suggesting that the company is outperforming its peers in generating returns for shareholders and effectively deploying its assets. The company's revenue is primarily concentrated in India, with no disclosed international operations in the latest financial snapshot. This geographic concentration may expose the company to local economic and regulatory risks, but it also allows for focused operational control and market penetration. Linde India's business is not segmented into multiple product lines in the provided data, but its primary activity is the production and distribution of industrial gases. Looking at the growth trajectory, Linde India's revenue for the latest period was INR 24.85 billion. While the outlook for the current fiscal year is not explicitly provided, the company's capital expenditure suggests a strategic focus on expansion and infrastructure development. The negative free cash flow indicates that the company is prioritizing growth over immediate shareholder returns, which could lead to higher revenue in the future. The risk assessment for Linde India indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.01 is exceptionally low, suggesting a conservative capital structure with minimal reliance on debt financing. This low leverage reduces financial risk and provides flexibility for future growth initiatives. The dilution risk is also low, with no signs of imminent share issuance or dilution pressure in the near term. Recent events and filings do not show any material changes in the company's operations or financial position. The analyst estimates suggest a mean price target of INR 6,742.67, with a median of INR 6,150.00, indicating a generally positive outlook from the market. The mean recommendation of 3.33 (on a scale of 1 to 5) suggests a cautious approach, with one "buy" and one "hold" recommendation from analysts.
Key takeaways
  • Linde India has a strong ROE of 11.91% and ROA of 8.84%, outperforming industry medians.
  • The company's liquidity position is stable, with a current ratio of 0.95 and INR 1.26 billion in cash and equivalents.
  • Linde India's capital structure is conservative, with a debt-to-equity ratio of 0.01 and no immediate dilution risks.
  • The company is investing heavily in capital expenditures, indicating a focus on long-term growth.
  • Analysts have a cautiously positive outlook, with a mean price target of INR 6,742.67 and a mean recommendation of 3.33.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$24.85B
Gross profit$13.90B
Operating income$5.51B
Net income$4.55B
R&D
SG&A
D&A
SBC
Operating cash flow$5.84B
CapEx-$13.31B
Free cash flow-$7.64B
Total assets$51.43B
Total liabilities$13.23B
Total equity$38.20B
Cash & equivalents$1.26B
Long-term debt$423.7M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$38.20B
Net cash$837.3M
Current ratio0.9
Debt/Equity0.0
ROA8.8%
ROE11.9%
Cash conversion1.3%
CapEx/Revenue-53.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricLINDActivity
Op margin22.2%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin18.3%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin55.9%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-53.5%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity1.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Observations
IR observations
Mean price target6,742.67 INR
Median price target6,150.00 INR
High price target8,209.00 INR
Low price target5,869.00 INR
Mean recommendation3.33 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count1.00
Sell count0.00
Strong-sell count1.00
Mean EPS estimate57.52 INR
Last actual EPS53.33 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 05:05 UTC#0081dcbf
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 10:30 UTCJob: d473afcd